BABICH JOHN W.,BABICH John W.,ZIMMERMAN CRAIG N.,ZIMMERMAN Craig N.,MARESCA KEVIN P.,MARESCA Kevin P.
申请号：
SI200731686
公开号：
SI2097111T1
申请日:
2007.11.07
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
Compounds of Formula (Ia) wherein R is a C 6 -C 12 substituted or unsubstituted aryl, a C 6 -C 12 substituted or unsubstituted heteroaryl, a C 1 -C 6 substituted or unsubstituted alkyl or -NRR, Q is C(O), O, NR, S, S(O) 2 , C(O) 2 (CH2)p Y is C(O), O, NR, S, S(O) 2 , C(O) 2 (CH2)p Z is H or C 1 -C 4 alkyl, R is H, C(O), S(O) 2 , C(O) 2 , a C 6 -C 12 substituted or unsubstituted aryl, a C 6 -C 12 substituted or unsubstituted heteroaryl or a C 1 -C 6 substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C 6 -C 12 heteroaryl, - NRR or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
